NovaBay Pharmaceuticals, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2015 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
NovaBay Pharmaceuticals, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2015 to Q3 2024.
  • NovaBay Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$1.21M, a 31% increase year-over-year.
  • NovaBay Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$10.1M, a 26.3% increase year-over-year.
  • NovaBay Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$9.64M, a 9.13% increase from 2022.
  • NovaBay Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$10.6M, a 82.1% decline from 2021.
  • NovaBay Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$5.82M, a 47.2% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$10.1M -$1.21M +$545K +31% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 -$10.7M -$1.59M +$451K +22.2% Apr 1, 2024 Jun 30, 2024 10-Q 2024-11-07
Q1 2024 -$11.1M -$3.21M -$1.48M -84.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-11-07
Q4 2023 -$9.64M -$4.11M +$4.1M +49.9% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-26
Q3 2023 -$13.7M -$1.76M -$1.62M -1192% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 -$12.1M -$2.04M +$119K +5.52% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-07
Q1 2023 -$12.2M -$1.74M -$1.63M -1467% Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-07
Q4 2022 -$10.6M -$8.21M -$8.05M -5094% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-26
Q3 2022 -$2.56M -$136K +$2.15M +94.1% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$4.71M -$2.16M -$296K -15.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-09
Q1 2022 -$4.42M -$111K +$1.41M +92.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-09
Q4 2021 -$5.82M -$158K +$1.6M +91% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 -$7.42M -$2.29M +$932K +28.9% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$8.35M -$1.86M +$2.62M +58.5% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-14
Q1 2021 -$11M -$1.52M +$64K +4.05% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-14
Q4 2020 -$11M -$1.75M +$932K +34.7% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-29
Q3 2020 -$12M -$3.22M -$2.94M -1042% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 -$9.03M -$4.48M -$1.98M -79.2% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-12
Q1 2020 -$7.05M -$1.58M +$2.61M +62.2% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-12
Q4 2019 -$9.66M -$2.69M -$1.42M -112% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-29
Q3 2019 -$8.24M -$282K +$1.26M +81.7% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 -$9.5M -$2.5M -$912K -57.4% Apr 1, 2019 Jun 30, 2019 10-Q 2020-11-12
Q1 2019 -$8.58M -$4.19M -$2.04M -94.8% Jan 1, 2019 Mar 31, 2019 10-Q 2020-11-12
Q4 2018 -$6.55M -$1.27M -$2.06M -260% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-25
Q3 2018 -$4.48M -$1.54M +$909K +37.1% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 -$5.39M -$1.59M +$149K +8.57% Apr 1, 2018 Jun 30, 2018 10-Q 2019-11-07
Q1 2018 -$5.54M -$2.15M +$1.86M +46.4% Jan 1, 2018 Mar 31, 2018 10-Q 2019-11-07
Q4 2017 -$7.4M $793K +$2.44M Oct 1, 2017 Dec 31, 2017 10-K 2020-03-26
Q3 2017 -$9.84M -$2.45M +$1.29M +34.5% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 -$11.1M -$1.74M +$952K +35.4% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 -$12.1M -$4.01M +$1.07M +21% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 -$13.2M -$1.65M +$2.56M +60.8% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-29
Q3 2016 -$15.7M -$3.74M +$1.51M +28.7% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
Q2 2016 -$17.2M -$2.69M +$2.2M +45% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-10
Q1 2016 -$19.4M -$5.08M -$437K -9.42% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-11
Q4 2015 -$19M -$4.2M Oct 1, 2015 Dec 31, 2015 10-K 2018-03-21
Q3 2015 -$5.24M Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-10
Q2 2015 -$4.89M Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-11
Q1 2015 -$4.64M Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.